Prudential Financial’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,682
| Closed | -$231K | – | 2737 |
|
|
2021
Q3 | $231K | Sell |
1,682
-98
| -6% | -$13.5K | ﹤0.01% | 2430 |
|
|
2021
Q2 | $223K | Hold |
1,780
| – | – | ﹤0.01% | 2421 |
|
|
2021
Q1 | $242K | Sell |
1,780
-688
| -28% | -$93.5K | ﹤0.01% | 2345 |
|
|
2020
Q4 | $315K | Sell |
2,468
-16
| -0.6% | -$2.04K | ﹤0.01% | 2231 |
|
|
2020
Q3 | $280K | Sell |
2,484
-36,263
| -94% | -$4.09M | ﹤0.01% | 2186 |
|
|
2020
Q2 | $3.69M | Sell |
38,747
-52,148
| -57% | -$4.97M | 0.01% | 1081 |
|
|
2020
Q1 | $8.17M | Buy |
90,895
+86,509
| +1,972% | +$7.77M | 0.02% | 714 |
|
|
2019
Q4 | $232K | Buy |
+4,386
| New | +$232K | ﹤0.01% | 2292 |
|
|
2019
Q2 | – | Sell |
-4,733
| Closed | -$221K | – | 2510 |
|
|
2019
Q1 | $221K | Buy |
+4,733
| New | +$221K | ﹤0.01% | 2295 |
|
|
2018
Q4 | – | Sell |
-14,379
| Closed | -$823K | – | 2474 |
|
|
2018
Q3 | $823K | Sell |
14,379
-31,894
| -69% | -$1.83M | ﹤0.01% | 1926 |
|
|
2018
Q2 | $2.25M | Sell |
46,273
-64,820
| -58% | -$3.14M | ﹤0.01% | 1588 |
|
|
2018
Q1 | $4.34M | Sell |
111,093
-49,017
| -31% | -$1.92M | 0.01% | 1229 |
|
|
2017
Q4 | $6.92M | Buy |
160,110
+79,100
| +98% | +$3.42M | 0.01% | 1023 |
|
|
2017
Q3 | $3.02M | Buy |
+81,010
| New | +$3.02M | ﹤0.01% | 1377 |
|
|
2017
Q1 | – | Sell |
-73,730
| Closed | -$1.88M | – | 2387 |
|
|
2016
Q4 | $1.88M | Sell |
73,730
-100
| -0.1% | -$2.55K | ﹤0.01% | 1573 |
|
|
2016
Q3 | $2.67M | Sell |
73,830
-7,670
| -9% | -$278K | ﹤0.01% | 1367 |
|
|
2016
Q2 | $2.77M | Sell |
81,500
-8,700
| -10% | -$296K | ﹤0.01% | 1400 |
|
|
2016
Q1 | $2.38M | Buy |
90,200
+21,500
| +31% | +$567K | ﹤0.01% | 1475 |
|
|
2015
Q4 | $3.35M | Buy |
+68,700
| New | +$3.35M | 0.01% | 1258 |
|